These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11346934)

  • 21. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of the regional lymph nodes following breast-conservation therapy for early-stage breast cancer: an evolving paradigm.
    Warren LE; Punglia RS; Wong JS; Bellon JR
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):772-7. PubMed ID: 25585780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Breast-conserving surgery in breast cancer].
    Ruggiero R; Procaccini E; Freda F; Iovino F; Irlandese E; Gili S; Lo Schiavo F
    G Chir; 2005; 26(11-12):449-52. PubMed ID: 16472427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with breast cancer and positive sentinel nodes: axillary dissection or axillary radiotherapy?
    Zippel D; Papa M
    Arch Surg; 2003 Oct; 138(10):1159. PubMed ID: 14557139
    [No Abstract]   [Full Text] [Related]  

  • 25. [Breast-conserving surgery for ductal carcinoma in situ of the breast].
    Shimada A
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():528-32. PubMed ID: 23350456
    [No Abstract]   [Full Text] [Related]  

  • 26. [Conservative surgery and radiation therapy in the treatment of operable breast cancer].
    Sun M; Wei S; Yi L
    Zhonghua Wai Ke Za Zhi; 1995 Oct; 33(10):606-8. PubMed ID: 8731894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
    Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
    Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
    Vitucci C; Tirelli C; Graziano F; Santoro E
    J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Local recurrence of ductal in situ carcinoma of the breast].
    Dunst J
    Strahlenther Onkol; 1999 Jul; 175(7):348-9. PubMed ID: 10432998
    [No Abstract]   [Full Text] [Related]  

  • 31. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer.
    Jacobson JA; Danforth DN; Cowan KH; d'Angelo T; Steinberg SM; Pierce L; Lippman ME; Lichter AS; Glatstein E; Okunieff P
    N Engl J Med; 1995 Apr; 332(14):907-11. PubMed ID: 7877647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ductal carcinoma in situ--current management.
    O'Sullivan MJ; Morrow M
    Surg Clin North Am; 2007 Apr; 87(2):333-51, viii. PubMed ID: 17498530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853].
    Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):193-4. PubMed ID: 11355583
    [No Abstract]   [Full Text] [Related]  

  • 35. Altered lymphatic drainage after breast-conserving surgery and axillary node dissection: local recurrence with contralateral intramammary nodal metastases.
    Wellner R; Dave J; Kim U; Menes TS
    Clin Breast Cancer; 2007 Feb; 7(6):486-8. PubMed ID: 17386126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors for local recurrence and distant metastases after breast conserving therapy of ductal carcinoma in situ].
    Sack H
    Strahlenther Onkol; 2001 Oct; 177(10):557. PubMed ID: 11680022
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
    Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
    Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
    Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgery for early and minimally invasive breast cancer.
    Graves TA; Bland KI
    Curr Opin Oncol; 1996 Nov; 8(6):468-77. PubMed ID: 8971466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumorectomy plus irradiation in ductal in-situ carcinoma].
    Dunst J
    Strahlenther Onkol; 1996 Jun; 172(6):344-5. PubMed ID: 8677509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.